Avaleht › Pehme koe sarkoom › New York

Pehme koe sarkoom kliinilised uuringud osariigis New York

27 uuringut haiguse Pehme koe sarkoom jaoks otsivad osalejaid osariigis New York.

Linnad osariigis New York

Ametlik uuringutekst (inglise keeles)

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

Memorial Sloan Kettering Cancer Center, New York

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06942442

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

VärbamineVaatlusuuringTerved vabatahtlikud oodatud

Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069

A Study of CRD3874-SI in People With Solid Tumors

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
ja veel 1

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. sept 2026 · NCT06021626

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center, New York

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. sept 2026 · NCT06797999

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

VärbamineFaas 1

Vanused 12–85 · Kõik sood · Uuendatud 8. sept 2026 · NCT03715933

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

New York University Langone Health, New York

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT05732831

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center, New York

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT04577014

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT06644755

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Montefiore Medical Center, The Bronx

VärbamineFaas 1/2

Vanused 12–40 · Kõik sood · Uuendatud 3. sept 2026 · NCT07725380

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
ja veel 1

Värbamine

Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT05837767

Actinium Therapy for Late-stage Aggressive Sarcomas

Memorial Sloane Kettering Cancer Center, New York

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. aug 2026 · NCT07156565

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Northwell Health Cancer Institute, Lake Success

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT06975293

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Roswell Park Cancer Institute, Buffalo

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. aug 2026 · NCT03965234

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. aug 2026 · NCT06242470

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

Memorial Sloan Kettering Commack (Consent and Follow-Up), Commack
Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
ja veel 1

VärbamineVaatlusuuring

Kõik vanused · Kõik sood · Uuendatud 30. juuli 2026 · NCT00579566

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
ja veel 1

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. juuli 2026 · NCT07089992

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Zai Lab Site 02002, New York

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. juuli 2026 · NCT07374848

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

VärbamineVaatlusuuringTerved vabatahtlikud oodatud

Vanused 19–110 · Kõik sood · Uuendatud 29. juuni 2026 · NCT02012699

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activites), New York
ja veel 1

Värbamine

Vanused 18 ja vanemad · Kõik sood · Uuendatud 15. mai 2026 · NCT06129903

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
ja veel 1

VärbamineFaas 2

Vanused 12 ja vanemad · Kõik sood · Uuendatud 23. apr 2026 · NCT04332874

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

Roswell Park Comprehensive Cancer Center, Buffalo

VärbamineVaatlusuuring

Vanused 12–70 · Kõik sood · Uuendatud 15. apr 2026 · NCT07402577

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Centre, New York

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 12. märts 2026 · NCT05755113

Phase II Trial of Lung Chemoemobolization

Memorial Sloan Kettering Cancer Center, New York

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. märts 2026 · NCT05672108

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
New York Medical Center/ Maria Fareri Children's Hospital, Valhalla

VärbamineFaas 1/2

12 Months – 40 Years · Kõik sood · Uuendatud 5. veebr 2026 · NCT03465592

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Memorial Sloan Kettering Cancer Center, New York

VärbamineFaas 1/2

Vanused 2–30 · Kõik sood · Uuendatud 3. veebr 2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Children's Hospital at Montefiore, The Bronx

VärbamineFaas 2

18 Months – 40 Years · Kõik sood · Uuendatud 12. aug 2025 · NCT05135975

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Memorial Sloan-Kettering Cancer Center, New York

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. nov 2024 · NCT05824975

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.